Cic edizioni internazionali
Functional Neurology

Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey

Original Article, 253 - 258
doi: 10.11138/FNeur/2013.28.4.253
Tag this article
Abstract
Enhanced HTML Full text PDF
The aim of this survey was to provide an overview of important issues relating to therapeutic strategies based on botulinum toxin type A injection for the treatment of patients with neurological disorders.
Two hundred and ten physicians from neurology and neurorehabilitation units in Italian hospitals answered a questionnaire exploring some clinical aspects of the use of botulinum toxin type A in patients with spasticity/dystonia. 66% of the physicians treated patients with dystonia, 80% treated adults with spasticity, and 35% treated children with cerebral palsy.
Palpation with no instrumental guidance was the injection technique most commonly used for treating patients with dystonia, spasticity and cerebral palsy; 57% of the physicians evaluated patients instrumentally before toxin injection, while 45% assessed postinjection improvements by instrumental means; 78% of the physicians prescribed (when appropriate) rehabilitation procedures after toxin injection. Our results seem to show that the routine use of botulinum toxin in clinics is far from standardized.

Vol. XXXIV (No. 2) 2019 April/June

  1. The nine circles of EBM hell
    Iosa M., Antonucci G., Paolucci S.
  2. The impact of an aquatic exercise program on BDNF levels in Parkinson’s disease patients: short-and long-term outcomes
    da Silva Germanos S., Vieira B., Reichert Vital da Silva I., da Cunha J.J., Nique S., Striebel V., Pochmann D., Rostirola Elsner V.
  3. Obstructive sleep apnea: neurocognitive and behavioral functions before and after treatment
    Turner K., Zambrelli E., Lavolpe S., Baldi C., Furia F., Canevini M.P.
  4. Risk factors and subtypes of ischemic stroke in young patients: an observational study from a teaching hospital in Saudi Arabia
    Shahid R.
  5. Wearable sensors, cerebral palsy and gait assessment in everyday environments: is it a reality? – A systematic review
    Rozin Kleiner A.F., Bellomo A., Pagnussat A.S., de Athayde Costa e Silva A., Sforza C., Cicuto Ferreira Rocha N.A.
  6. ERIGO: a possible strategy to treat orthostatic hypotension in progressive supranuclear palsy? A feasibility study
    Sorbera C., Portaro S., Cimino V., Leo A., Accorinti M., Silvestri G., Bramanti P., Naro A., Calabrò R.S.
  7. Influence of neurorehabilitation on stroke-induced modifications of the quadriceps muscle in elderly subacute stroke patients with paresis
    Ciancarelli I., Mariangeli F., Tonin P., Ciofani E., Garo M.L., Tozzi Ciancarelli M.G.
  8. Motor cortex function in fibromyalgia: a pilot study involving near-infrared spectroscopy and co-recording of laser-evoked potentials
    Gentile E., Ricci K., Delussi M., de Tommaso M.
  9. Low back pain related to a sacral insufficiency fracture: role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain
    de Sire A., Baricich A., Minetto M.A., Cisari C., Invernizzi M.
  10. Rehabilitation assisted by robotic and electromechanical devices for persons with neurological disabilities: an Italian consensus conference
    Boldrini P., Bonaiuti D., Mazzoleni S., Posteraro F.
Last Viewed articles: la lista degli ultimi x visitati.
  1. Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey
    Smania N., Colosimo C., Bentivoglio A.R., Sandrini G., Picelli A.
    doi: 10.11138/FNeur/2013.28.4.253
credits